CMO/CDMO Market

The CMO/CDMO Market Is Segmented By Services (Drug Development Services, Manufacturing Services, Fill-Finish Services, Advance Therapy Services, Commercial Manufacturing Services, Technology Transfer Services, And Quality And Compliance Services), Modality (Small Molecules, Classical Biologics, Microbial Biologics, Cell & Gene Therapies, Oligonucleotides, And Vaccines), Stage Of Engagement (Phase I, Phase II/III Clinical, Commercial Launch, And Lifecycle Management), Molecule Complexity (Simple Apis, Complex Apis (NBCDs), And Highly Hazardous Apis), Therapeutic Area (Oncology, Cardiovascular Diseases, Infectious Diseases, Metabolic Disorders, Neurology, Immunology, Respiratory Disorders, Urology, Dermatology, Ophthalmology, General Health, And Others), and Client Type (Large Pharma, Mid-Size Pharma, Biotech Pharma, Generic Companies, And Specialty Pharma). Forecast For 2026 to 2036.